Caffeine Mouth Rinsing at Different Doses in Female Team-Sport Athletes: A Randomized, Double-Blind, Placebo-Controlled Trial
MORISINGFEMALE
1 other identifier
interventional
13
1 country
1
Brief Summary
Objective: To evaluate the effects of different caffeine mouth rinse concentrations (1%, 2%, and 3%) on Running Anaerobic Sprint Test (RAST) performance in female team-sport athletes. Main Questions:
- 1.Do caffeine mouth rinses improve RAST performance in female team-sport athletes?
- 2.Do different caffeine mouth rinse concentrations affect ratings of perceived exertion (RPE)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2024
CompletedFirst Submitted
Initial submission to the registry
August 11, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedAugust 19, 2025
August 1, 2025
1.2 years
August 11, 2025
August 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Running-based anaerobic sprint test (RAST protocol)
The RAST was comprised of six 35 m sprints at maximum effort, each of which was followed by a 10 s passive rest period (including deceleration phase). Participants rinsed the solution in the final 5 s of the rest period accompanied by the counting of the tester, and then sprint back to the first timing gate with "GO" command. This was repeated until six sprints had been accomplished. Participants began to sprint running for a maximum of one step before the timing gate and were instructed not to decelerate before passing through the timing gate. Using a system of photocells (Newtest Powertimer 300-series, Newtest Oy, Tyrnävä, Finland), which was placed at the beginning and the end of the 35 m, the duration of each 35 m sprint running time was recorded. Using time of each sprint attempt, 1-) fastest sprint time, 2-) mean sprint time, and 3-) fatigue index were recorded
2-week
Secondary Outcomes (1)
Rating of perceived exertion (RPE)
2-weeks
Study Arms (4)
Placebo (water)
PLACEBO COMPARATORPlacebo: Mouth rinse with plain water, containing no caffeine, serving as the control condition.
Low mouth rinse caffeine concentration
EXPERIMENTALLow caffeine concentration: Mouth rinse containing 1% caffeine solution (based on weight/volume).
Moderate mouth rinse caffeine concentration
EXPERIMENTALModerate caffeine concentration: Mouth rinse containing 2% caffeine solution (based on weight/volume).
High mouth rinse caffeine concentration
EXPERIMENTALModerate caffeine concentration: Mouth rinse containing 3% caffeine solution (based on weight/volume).
Interventions
Placebo: Mouth rinse with plain water, containing no caffeine, serving as the control condition.
Arm Description: Low caffeine concentration: Mouth rinse containing 1% caffeine solution (based on weight/volume).
Moderate caffeine concentration: Mouth rinse containing 2% caffeine solution (weight/volume).
High caffeine concentration: Mouth rinse containing 3% caffeine solution (weight/volume).
Eligibility Criteria
You may qualify if:
- Female team sports athletes aged between 18 and 35 years.
- Currently engaged in team sports.
- Non-smoker.
You may not qualify if:
- Participants were excluded if they met any of the following conditions.
- Presence of a musculoskeletal injury within the six months prior to the study.
- Current smoker.
- Use of nutritional supplements or ergogenic aids that could influence sprint running performance (e.g., beta-alanine, creatine).
- Use of oral contraceptives.
- Known allergy to caffeine.
- Failure to meet the training requirement of at least six hours of team-based practice, a minimum of three days per week, over the past year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Pontificia Comillaslead
- Eastern Mediterranean Universitycollaborator
- Northumbria Universitycollaborator
- Universidad Francisco de Vitoriacollaborator
- Ankara Universitycollaborator
Study Sites (1)
Eastern Mediterranean University
Mersin, SBF C 116, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2025
First Posted
August 19, 2025
Study Start
September 24, 2023
Primary Completion
December 1, 2024
Study Completion
December 22, 2024
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
IPD will be shared if previously is required